← Back to graph
Supplement

Bifidobacterium animalis subsp lactis BB-12

Selected indexed studies

  • The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12(®) in infant colic: A randomised, double blind, placebo-controlled trial. (Aliment Pharmacol Ther, 2020) [PMID:31797399]
  • Understanding the probiotic health benefits of Bifidobacterium animalis subsp. lactis, BB-12™. (Front Microbiol, 2025) [PMID:40673154]
  • The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®). (Microorganisms, 2014) [PMID:27682233]

_Worker-drafted node — pending editorial review._

Connections

Bifidobacterium animalis subsp lactis BB-12 helps

Sources

Local graph